Tag: Stevin Zorn
MindImmune Therapeutics $30M funding round, 6th tenant set stage for Ocean...
PROVIDENCE – As the prevalence of Alzheimer’s disease grows, typical treatments for the neurodegenerative illness are rooted in an approach that’s about 90 years old.
And that treatment shows...
MindImmune Therapeutics raises $30M in Series A funding, appoints new CEO
PROVIDENCE – MindImmune Therapeutics, a company developing innovative treatments for Alzheimer's and other neurodegenerative diseases, announced this week that it has raised $30 million...
Five Questions With: Stevin Zorn
Stevin Zorn is CEO, president and co-founder of MindImmune Therapeutics Inc., a drug discovery company launched to develop new treatments for Alzheimer’s and other central...
MindImmune Therapeutics agrees to acquire two programs from H. Lundbeck
SOUTH KINGSTOWN –MindImmune Therapeutics Inc. has entered into agreements with H. Lundbeck A/S to acquire programs and will develop candidates from these programs as...
MindImmune Therapeutics closes $500K seed round led by Slater Fund
PROVIDENCE – MindImmune Therapeutics Inc., a pharmaceutical startup, closed its second seed round of $500,000 on Monday.
The round was led by a $250,000 investment...
- Featured Event -
